|Silent period and closed window||14.1.–14.2.2020|
|Full-year 2019 financial statements||14.2.2020|
|Annual Review 2019||Week 13 (23.–29.3.2020)|
|Annual General Meeting||6.4.2020|
|Silent period and closed window||14.7.–14.8.2020|
|Half-year 2020 financial review||14.8.2020|
Regularly published financial reports are always preceded by a silent period of 30 days, during which Remedy does not issue statements on the financial position, business operations, markets or prospects.
During the silent period, the senior management of the company does not meet with investors, analysts or other capital market representatives, nor do they give interviews on the financial position of the company.